U.S., May 8 -- ClinicalTrials.gov registry received information related to the study (NCT06961305) titled 'A Post-Marketing Study of Alexa Medium for Lip Volume Restoration in Adult Women' on April 29.

Brief Summary: This post-marketing, prospective, multicentre, single-arm, open-label clinical investigation aimed to evaluate the safety, tolerability, and effectiveness of the injectable medical device Alexa Medium (based on cross-linked hyaluronic acid) for the correction of lip volume loss in adult women. Participants received one or two injections of the product, and effectiveness was assessed using the Global Aesthetic Improvement Scale (GAIS) and the Medicis Lip Fullness Scale (MLFS). Safety data were collected at each visit. The study...